Free Market Health acquired Beeline Rx, a tech company that streamlines the prior authorization process for specialty drugs. The post Free Market Health Acquires Beeline Rx to Streamline Specialty Prior Auth appeared first on MedCity News.
KFF Health News and KCUR are following the stories of people injured during the Feb. 14 mass shooting at the Kansas City Chiefs Super Bowl celebration. Listen to how survivors are seeking a sense of safety. KANSAS CITY, Mo. — Twenty-four minutes before the mass shooting at the Kansas City Chiefs Super Bowl victory parade…
The Improving Care and Access to Nurses (ICAN) Act would cut the red tape for advanced practice nurses to provide care, says AANA’s president
Abeona Therapeutics makes Zevaskyn by engineering a patient’s biopsied skin cells to express the collagen that they lack, then growing those cells into sheets that can be surgically applied to a wound. Abeona’s cell-based gene therapy is just the third FDA-approved treatment for epidermolysis bullosa, a rare disease that leads to skin described as thin…
By MIKE MAGEE Clearly the Harris-Walz ticket has been doing their homework. Last week, the book above was spotted on one prominent thought-leader’s pile: “Human Evolutionary Demography.” It’s a 780 page academic Tour de force read by veteran scientist Oskar Burger, leader of the Max Planck Institute for Demographic Research and the Laboratory of Evolutionary…
AI addresses the disconnect between recommended guidelines and action by increasing engagement with personalized, actionable education and updates at appropriate times, The post AI in Clinical Settings: Balancing Innovation, Patient Care, and Personalized Medicine appeared first on MedCity News.
No revolutionary naval vessels, fighter planes, or weapon systems were involved. Rather, this one was about staffing military healthcare facilities. Make no mistake, though: It’s also revolutionary. The post A Revolution in Military Medical Staffing is Afoot and Private Sector Firms are Playing a Big Part appeared first on MedCity News.
Editas Medicine says its in vivo gene-editing therapy for hemoglobinopathies has best-in-class potential, but the company plans to out-license or partner that program. Editas is shifting focusing to in vivo gene-editing therapies. The post Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D appeared first on MedCity News.
If healthcare leaders hope to demonstrate ROI on AI investments, reduce clinician burnout, and meet compliance requirements, they must first ensure the integrity of their clinical data. The post How to Take Out the Data Garbage and Create AI Gold appeared first on MedCity News.
Zepbound’s clinical tests in obstructive sleep apnea showed improvement in breathing disruptions that were accompanied by reductions in body weight. The new approval gives the Eli Lilly medicine the opportunity to become a blockbuster seller in yet another indication. The post Eli Lilly’s Zepbound Becomes First FDA-Approved Drug Therapy for Sleep Apnea appeared first on…